Profiler

Genedata Profiler is an award-winning solution utilized by global biopharma and biotech companies to enhance translational and clinical research pipelines, thereby advancing the development of precision medicine. It facilitates the integration of biomarker data within and across clinical programs, including the digitalization of translational workflows associated with clinical studies.

With the support of Genedata Profiler, Egis has developed the PREDYSTIC® Infliximab RA Kit, which aids in tailoring RA treatments to patients who will benefit most. This platform is employed in a validated environment, democratizing access to integrated data in both translational research and clinical settings.

Merck has collaborated with Genedata to create a digital biomarker research platform, enhancing the utilization of clinical and translational data for innovative biomarker and drug target discovery. The platform's ability to analyze large volumes of high-dimensional ‘omics data is crucial for organizations with expanding translational and clinical research projects.

Key benefits of using Genedata Profiler include:

• End-to-end enterprise software for harmonizing dispersed data analysis pipelines.
• Expertise in big multi-omics data analysis to accelerate precision biomarker discovery.
• Support for developing safe, targeted, and effective cancer therapeutics.

As clinical and pre-clinical programs grow, Genedata Profiler, along with Genedata Managed IT Services, continues to assist in developing therapeutics, ensuring reliable and effective research outcomes.